Study

Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. – Cost Effective Supplements

Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/26066335


Conclusion of this study

Furthermore, curcumin decreases inflammatory cytokines interleukin 1β and tumor necrosis factor α level, increases plasma brain-derived neurotrophic factor levels, and decreases salivary cortisol concentrations compared with placebo group. These findings indicate the potential benefits of further implications of supplementary administration of curcumin to reverse the development of depression and enhance the outcome of antidepressants treatment in major depressive disorder.


Supplements analyzed in this study

Curcumin

Health conditions analyzed in this study

Depression


Moderately Positive
Curcumin


Functions related to this study

Emotional health


Moderately Positive
Curcumin

Heart health


Slightly Positive
Curcumin

Immunity


Slightly Negative
Curcumin

Mental health


Slightly Positive
Curcumin

Overall health


Slightly Positive
Curcumin


Body systems related to this study


Cardiovascular System

Endocrine System

Immune System

Nervous System
Scroll to top